XP Chemistries AB (XPC) - Cash Flow Conversion Efficiency
Based on the latest financial reports, XP Chemistries AB (XPC) has a cash flow conversion efficiency ratio of -0.113x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr-4.49 Million ≈ $-482.75K USD) by net assets (Skr39.57 Million ≈ $4.26 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See XP Chemistries AB balance sheet independence to measure how much of total assets are equity-financed.
XP Chemistries AB - Cash Flow Conversion Efficiency Trend (2020–2024)
This chart illustrates how XP Chemistries AB's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check XP Chemistries AB investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
XP Chemistries AB Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of XP Chemistries AB ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Jupiter Neurosciences, Inc. Common Stock
NASDAQ:JUNS
|
1.293x |
|
2CUREX AB SEK-10
F:2QE
|
N/A |
|
Cerillion PLC
LSE:CER
|
0.027x |
|
Eastfield Resources Ltd
V:ETF
|
-0.094x |
|
Xamble Group Ltd
AU:XGL
|
-5.149x |
|
Airtouch Solar Ltd
TA:ARTS
|
-0.081x |
|
Hopening SA
PA:MLHPE
|
N/A |
|
Frp Advisory Group Plc
LSE:FRP
|
0.275x |
Annual Cash Flow Conversion Efficiency for XP Chemistries AB (2020–2024)
The table below shows the annual cash flow conversion efficiency of XP Chemistries AB from 2020 to 2024. For the full company profile with market capitalisation and key ratios, see XPC stock market capitalisation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | Skr21.56 Million ≈ $2.32 Million |
Skr-7.69 Million ≈ $-827.95K |
-0.357x | -0.90% |
| 2023-12-31 | Skr25.69 Million ≈ $2.76 Million |
Skr-9.08 Million ≈ $-977.45K |
-0.354x | -4.32% |
| 2022-12-31 | Skr29.07 Million ≈ $3.13 Million |
Skr-9.85 Million ≈ $-1.06 Million |
-0.339x | -112.67% |
| 2021-12-31 | Skr31.30 Million ≈ $3.37 Million |
Skr-4.99 Million ≈ $-536.88K |
-0.159x | -- |
| 2020-12-31 | Skr4.57 Million ≈ $492.07K |
Skr0.00 ≈ $0.00 |
0.000x | -- |
About XP Chemistries AB
XP Chemistries AB (publ), a biotechnology company, engages in the development and production of forest-based capsaicin and analogues. It offers animal feed ingredients; personal care and cosmetic ingredients; pure capsaicinoids; and self-defense spray ingredients. The company was incorporated in 2018 and is based in Sundsvall, Sweden.